Jamieson Bondarenko serves as Executive at BriaCell Therapeutics Corp., where they oversee executive responsibilities. Since joining the company, Jamieson Bondarenko has executed 2 insider transactions totaling $245.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 28, 2022 involved purchasing 28,000 shares valued at $128.2K.
Jamieson Bondarenko currently holds 169,856 shares of BriaCell Therapeutics Corp. (BCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jamieson Bondarenko has been a net buyer of BCTX stock. They have purchased $245.9K and sold $0 worth of shares.
Jamieson Bondarenko's most recent insider trade was on Dec 28, 2022, when they purchased 28,000 shares at $4.58 per share.
Get notified when new Form 4 filings are submitted
| $5.35 |
| Discretionary |